Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake

By Budygin E.A.   Gainetdinov R.R.   Kilpatrick M.R.   Rayevsky K.S.   Mannisto P.T.   Wightman R.M.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 125-131

Elsevier

Access to resources Recommend Favorite

BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of l-DOPA to the brain and reduces its O-methylation

By Parada A.   Loureiro A.I.   Vieira-Coelho M.A.   Hainzl D.   Soares-da-Silva P.  

European Journal of Pharmacology, Vol. 420, Iss. 1, 2001-05 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[ 18 F]l-DOPA

By Doudet D.J.   Chan G.L.Y.   Holden J.E.   Pate B.D.   Morrison K.S.   Calne D.B.   Ruth T.J.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 31-38

Elsevier

Access to resources Recommend Favorite

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 3, 2012-05 ,pp. : 251-263

Bentham Science Publishers

Access to resources Recommend Favorite

Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor

By Bonifacio M.J.   Vieira-Coelho M.A.   Soares-da-Silva P.  

European Journal of Pharmacology, Vol. 460, Iss. 2, 2003-01 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite